WARNHINWEISE Die angegebene empfohlene tgliche Verzehrmenge darf nicht berschritten werden
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
However, increased activity may expose underlying spinal issues that were previously unnoticed, especially if someone already has: disc bulges herniated discs degenerative disc disease Not all back pain is disc related, but certain symptoms may suggest nerve pressure or disc involvement
Buyers comparing GLP-related products can review Retatrutide alongside Semaglutide, Tirzepatide, and Cagrilintide
They dont care what the cause is